GPN Vaccines secures $18 million in Series B led by Forepont Capital, Kern Capital and Shearwater Capital
Amount Raised
$18 Million
Round Type
Series B
YarralumlaBiotechnologyInvestors
Description
Adelaide-based biotechnology company GPN Vaccines has secured $18 million in an oversubscribed Series B1 investment round co-led by Forepont Capital, Kern Capital, and Shearwater Capital. The funding will enable GPN Vaccines to continue the clinical evaluation of Gamma-PNTM, invest in a pipeline of new vaccine opportunities, and position the company for its next stage of development.
Quick answer
GPN Vaccines raised $18 Million in a Series B round, dated June 7, 2024. Investors: Shearwater Capital, Kern Capital and Forepont Capital. GPN Vaccines is based in Yarralumla, Australian Capital Territory, Australia.
- How much did GPN Vaccines raise?
- GPN Vaccines raised $18 Million in a Series B round on June 7, 2024.
- Who invested in GPN Vaccines?
- Shearwater Capital, Kern Capital and Forepont Capital are named as investors in this round.
- What does GPN Vaccines do?
- GPN Vaccines is an Adelaide-based biotechnology company founded in 2017.
- Where is GPN Vaccines based and how big is it?
- GPN Vaccines is based in Yarralumla, Australian Capital Territory, Australia. Fundz records about 36 employees.
- Who are the decision-makers at GPN Vaccines?
- Fundz holds 4 contacts at GPN Vaccines, including the Director, International (Asia). Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as GPN Vaccines that raised within 45 days of this round, from Fundz verified event records.
- Hepion Pharmaceuticals raised $2.9M on July 19, 2024.
- Biodexa Pharmaceuticals raised $5M on July 19, 2024.
- Rona Therapeutics raised $35M (Series A) on July 19, 2024.
- GRO Biosciences raised $60M (Series B) on July 19, 2024.
- Ignitedata (Delaware) raised $500K on July 19, 2024.
- Ensho Therapeutics raised $400K on July 19, 2024.
Who to call at GPN Vaccines, and when
A new round usually means GPN Vaccines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GPN Vaccines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GPN Vaccines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GPN Vaccines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GPN Vaccines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGPN Vaccines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.